In a case–control study by [152], which included 180 Alzheimer’s disease cases and 40 TREM-2 risk variant carriers, higher CSF sTREM-2 levels were observed in patients with the disease than controls and also in R47H carriers compared to noncarriers [152]. Here, TREM2 is linked to Alzheimer disease.